ARID1A and endometrioid adenocarcinoma: Complete loss of ARID1A expression or clonal ARID1A mutation is rare in atypical endometrial hyperplasia while up to one-third of endometrioid carcinomas lose ARID1A expression or harbor somatic ARID1A mutations.